13F Holdings
中文EN

SNWV SANUWAVE Health, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1417663 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY128.0%
TTM EPS YoY76.9%
Revenue 3-yr CAGR29.5%
Net income 3-yr CAGR—

Margins

Gross margin76.0%
Operating margin-4.5%
Net margin6.3%
FCF margin6.3%
EBITDA margin-1.7%

Returns

ROE—
ROA7.6%
ROIC (approx.)-124.0%
Asset turnover1.20x

Leverage & solvency

Liabilities / assets91.2%
Debt / equity0.00x
Current ratio1.18x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.28x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue1.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$44.05M$32.63M$20.40M$16.74M$13.01M
Cost of revenue$10.08M$8.08M$6.04M$4.33M$4.99M
Gross profit$33.97M$24.55M$14.36M$12.41M$8.02M
R&D expense$1.35M$673,000$579,000$567,000$1.10M
SG&A expense$19.37M$12.92M$8.67M$12.56M$11.69M
Operating income$4.95M$3.85M-$540,000-$8.95M-$14.14M
Interest expense—$12.56M—$12.77M$6.88M
Pretax income$11.90M-$33.06M-$25.78M-$10.28M-$27.21M
Income tax$86,000$27,000$4,000$2,000$28,000
Net income$11.81M-$33.08M-$25.81M-$10.29M-$27.26M
EBITDA$5.92M$4.64M$488,000-$8.00M-$12.91M
EPS (basic)1.38-7.41-12.19-0.02-0.05
EPS (diluted)0.41-7.41-12.19-0.02-0.05
Weighted avg. shares (diluted)9.08M4.46M2.12M549.47M518.36M
Balance sheet
Cash & equivalents$11.96M$10.24M$1.80M$1.15M$619,000
Receivables$5.42M$3.33M$3.31M$4.03M$2.42M
Inventory$5.93M$4.15M$2.95M$868,000$1.04M
Current assets$24.63M$18.40M$9.78M$6.62M$4.40M
PP&E, net$1.97M$303,000$938,000$856,000$1.01M
Goodwill$7.26M$7.26M$7.26M$7.26M$7.26M
Intangibles$3.03M$3.73M$4.43M$5.14M$5.84M
Total assets$37.34M$30.12M$22.42M$19.87M$18.62M
Current liabilities$17.85M$45.42M$64.75M$60.22M$56.26M
Short-term debt$5.75M———$25.39M
Long-term debt$16.14M———$875,000
Total debt$21.89M———$26.26M
Total liabilities$35.72M$45.91M$65.59M$60.88M$57.58M
Shareholders' equity$1.62M-$15.79M-$44.55M-$41.01M-$38.96M
Net debt$9.93M———$25.64M
Shares outstanding8.59M8.54M3.04M548.74M481.62M
Cash flow statement
Operating cash flow$3.88M$2.46M-$4.54M-$17.17M-$6.41M
Capital expenditure$1.94M$490,000$0—$529,000
Free cash flow$1.93M$1.97M-$4.54M—-$6.94M
Investing cash flow$3.43M-$490,000$21,000$332,000-$529,000
Financing cash flow-$5.59M$6.35M$5.21M$17.38M$5.12M
Depreciation & amortization$974,000$788,000$1.03M$952,000$1.24M
Stock-based compensation$4.85M$1.51M$0—$0

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.